Blood-based circular RNAs emerge as a breakthrough early diagnostic tool for Alzheimer’s disease
-
-
REFERENCES
[1] Frisoni G B., Hansson O., Nichols E., et al. (2025). New landscape of the diagnosis of Alzheimer’s disease. Lancet 406:1389−1407. DOI:10.1016/S0140-6736(25)01294-2 [2] Villemagne V L., Burnham S., Bourgeat P., et al. (2013). Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective cohort study. Lancet Neurol. 12:357−367. DOI:10.1016/S1474-4422(13)70044-9 [3] Joling K J., Janssen O., Francke A L., et al. (2020). Time from diagnosis to institutionalization and death in people with dementia. Alzheimers Dement. 16:662−671. DOI:10.1002/alz.12063 [4] Phillips B., Sanford J., Janve V A., et al. (2026). Blood-based circular RNAs for early diagnosis of Alzheimer’s disease. Nat. Med. DOI:10.1038/s41591-026-04485-5 [5] 2026). Early detection of Alzheimer’s disease with circular RNA from blood. Nat. Med. 32: 2745–2746. DOI:10.1038/s41591-026-04563-8 -
ABOUT THIS ARTICLE
Cite this article:
Chen L., Sun F., Xi E., et al. (2026). Blood-based circular RNAs emerge as a breakthrough early diagnostic tool for Alzheimer’s disease. The Innovation Neurology 1:100003. https://doi.org/10.59717/j.xinn-tine.2026.100003
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Chen L., Sun F., Xi E., et al. (2026). Blood-based circular RNAs emerge as a breakthrough early diagnostic tool for Alzheimer’s disease. The Innovation Neurology 1:100003. https://doi.org/10.59717/j.xinn-tine.2026.100003
Format
Content
DownLoad:
-
Figure 1.
Schematic illustrations of the Blood-Based Circular RNAs acted as an Early Diagnostic Tool for Alzheimer’ s Disease.
